S&P 500 Financials Sector SEC Filings — January 29, 2026

30-01-2026

Lafayette Digital Acquisition Corp. I filed an 8-K on January 30, 2026 (AccNo: 0001213900-26-010254), disclosing an other event under Item 8.01 and financial statements and exhibits under Item 9.01, in connection with a merger/acquisition event. No specific details on parties, deal structure, valuation, financial metrics, synergies, regulatory pathway, or shareholder impacts are provided. Sector is not specified, and no quantitative data or scheduled events are mentioned.

• ·File size: 266 KB

30-01-2026

Praetorian Acquisition Corp. filed an 8-K on 2026-01-30 disclosing a merger/acquisition event under Item 8.01 Other Events, with Item 9.01 providing financial statements and exhibits. No specific deal structure, parties involved, valuation, strategic rationale, or quantitative metrics are disclosed in the filing summary. The announcement is informational without detailed terms or impacts.

• ·Filing Accession Number: 0001213900-26-010243
• ·Filing Size: 409 KB
• ·Sector: NOT_DISCLOSED

30-01-2026

30-01-2026

Gentex Corp filed an 8-K on January 30, 2026, under Item 2.02 reporting results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, margins, or period-over-period comparisons are disclosed in the provided filing details. This appears to be an earnings-related disclosure with no quantified metrics available.

30-01-2026

Moog Inc. filed a Form 8-K on January 30, 2026 (AccNo: 0001628280-26-004305), reporting Results of Operations and Financial Condition under Item 2.02, Other Events under Item 8.01, and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This multi-item filing appears informational without detailed performance data.

30-01-2026

Civitas Resources, Inc. disclosed in its 8-K filing on 2026-01-30 the completion of an acquisition or disposition of assets (Item 2.01) and termination of a material definitive agreement (Item 1.02), alongside notice of delisting or failure to satisfy listing standards (Item 3.01), material modifications to rights of security holders (Item 3.03), changes in control of the registrant (Item 5.01), departures/elections of directors and officers (Item 5.02), and amendments to articles of incorporation or bylaws (Item 5.03). While the transaction completion may realize value for target stakeholders, the delisting and changes in control introduce significant negative implications including reduced liquidity and altered governance. No financial metrics, deal values, or specific parties were disclosed.

30-01-2026

Mechanics Bancorp filed a Form 8-K on January 30, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific revenue, earnings, balance sheet metrics, period-over-period comparisons, or guidance details in the available summary. No positive or negative performance indicators were mentioned.

30-01-2026

News Corp filed an 8-K on January 30, 2026 (AccNo: 0001564708-26-000020, Size: 399 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other event, transaction, financial impacts, or contents of the exhibits are disclosed. This appears to be a multi-item filing with informational disclosures but lacks quantitative metrics or directional implications.

30-01-2026

30-01-2026

Regeneron Pharmaceuticals, Inc. filed a Form 8-K on January 30, 2026 (AccNo: 0000872589-26-000004, Size: 735 KB), reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. This is a multi-item filing focused on financial results disclosure. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information.

30-01-2026

30-01-2026

30-01-2026

Space Asset Acquisition Corp. filed an 8-K on January 30, 2026 (AccNo: 0001213900-26-010205), disclosing entry into a material definitive agreement under Item 1.01, likely related to a merger or acquisition. Additional items include unregistered sales of equity securities (Item 3.02), departures/elections of directors/officers and compensatory arrangements (Item 5.02), amendments to articles of incorporation or bylaws (Item 5.03), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No quantitative metrics, deal terms, parties, or performance data are disclosed.

30-01-2026

SmartStop Self Storage REIT, Inc. filed a Form 8-K on January 30, 2026, reporting under Item 8.01 (Other Events). No specific details of the event, financial metrics, transaction values, or impacts are disclosed in the provided filing information. No positive or negative developments, period-over-period comparisons, or scheduled events are mentioned.

• ·AccNo: 0001193125-26-031818
• ·Filing Size: 145 KB
• ·Event Type: General Filing
• ·Sector: NOT_DISCLOSED

30-01-2026

Dominion Energy, Inc. filed an 8-K on January 30, 2026, reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with a document size of 9 MB, suggesting exhibits such as presentations or financial statements may be attached. No specific financial metrics, transactions, guidance, or events are detailed in the provided filing information.

• ·AccNo: 0001193125-26-030493

30-01-2026

30-01-2026

QuantumScape Corp filed an 8-K on 2026-01-30 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individuals involved, reasons for change, or any quantitative data such as compensation amounts are disclosed. No positive or negative metrics, financial impacts, or governance implications are mentioned.

30-01-2026

ArcBest Corp /DE/ filed an 8-K on January 30, 2026 (AccNo: 0001104659-26-008222, Size: 16 MB), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits provided under Item 9.01. No specific revenue, earnings, margins, period-over-period comparisons, or other quantitative financial metrics are explicitly stated in the provided filing information. This represents a standard earnings-related disclosure with no directional performance indicators available.

• ·File size: 16 MB

30-01-2026

Autoliv Inc filed an 8-K on January 30, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. This is a multi-item filing typical for earnings releases, with no quantitative data available for analysis.

30-01-2026

SunPower Inc. filed a Form 8-K on 2026-01-30 reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and Item 3.02 unregistered sales of equity securities, with Item 9.01 for financial statements and exhibits. This is a multi-item mandatory disclosure with no specific transaction details, dollar values, terms, or financial impacts provided. No positive or negative metrics, period-over-period changes, or strategic context were disclosed.

30-01-2026

Flagstar Bank, National Association filed a Form 8-K on January 30, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, period-over-period comparisons, or guidance were mentioned. This is a standard earnings-related disclosure with no quantified metrics provided.

30-01-2026

ESS Tech, Inc. filed an 8-K on 2026-01-30 reporting Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No details on the agreement, transaction value, financial impacts, or other metrics are disclosed. AccNo: 0001628280-26-004263; File Size: 1 MB.

• ·Sector: not specified
• ·Source: us_sec
• ·File Size: 1 MB
• ·Multi-item filing: Yes (Items 1.01 and 9.01)
• ·Mandatory disclosure under SEC 8-K rules for Item 1.01

30-01-2026

SSR Mining Inc. filed a Form 8-K on January 30, 2026 (AccNo: 0000947871-26-000074), reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the core events, transactions, financial metrics, or quantitative data provided in the filing summary. No positive or negative metrics, period-over-period comparisons, or guidance changes are disclosed.

30-01-2026

Brand Engagement Network Inc. filed a multi-item 8-K on January 30, 2026, disclosing entry into a material definitive agreement under Item 1.01, creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, and unregistered sales of equity securities under Item 3.02, with additional other events under Item 8.01. While the material agreement may signal strategic funding or partnership opportunities, the new financial obligation introduces potential debt risks and the equity sales raise shareholder dilution concerns. No quantitative details such as transaction values, share counts, or financial impacts were disclosed.

30-01-2026

FG Nexus Inc. filed an 8-K on January 30, 2026, reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details, financial metrics, transactions, or performance data are disclosed in the provided filing information.

30-01-2026

GRI Bio, Inc. filed an 8-K on 2026-01-30 reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 includes financial statements and exhibits. No specific details, financial metrics, transaction values, positive or negative changes, or other quantitative data are disclosed.

30-01-2026

Bluejay Diagnostics, Inc. filed a Form 8-K on January 30, 2026, disclosing events under multiple items including Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing appears related to governance changes and shareholder vote outcomes, but no specific details on the nature of modifications, vote results, or financial impacts are provided. No quantitative metrics, positive or negative changes, or period-over-period comparisons are disclosed.

30-01-2026

Lake Superior Acquisition Corp filed an 8-K on 2026-01-30 announcing under Item 1.01 entry into a material definitive agreement related to a merger/acquisition event. Item 9.01 discloses financial statements and exhibits, likely including pro forma information and the agreement itself. No specific transaction terms, financial metrics, parties beyond the filer, valuations, synergies, or impacts are detailed in the provided filing summary.

30-01-2026

Twin Hospitality Group Inc. filed a Form 8-K on 2026-01-30 under Item 3.01 announcing a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No financial metrics, transaction values, guidance changes, or other quantitative details are disclosed. Sector is not specified.

• ·Accession Number: 0001493152-26-004291
• ·Filing size: 212 KB

30-01-2026

FIRST NORTHERN COMMUNITY BANCORP filed an 8-K on January 30, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but specific revenue, earnings, balance sheet changes, or other quantitative metrics are NOT_DISCLOSED in the provided information. No positive or negative performance indicators, period-over-period comparisons, or guidance revisions are detailed.

30-01-2026

NorthEast Community Bancorp, Inc./MD/ filed an 8-K on January 30, 2026 (AccNo: 0001104659-26-008167), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, guidance, or other quantitative financial metrics were disclosed in the provided filing information. This is a standard voluntary disclosure typically associated with quarterly or annual financial results announcement.

30-01-2026

Fat Brands, Inc. filed an 8-K on January 30, 2026 (AccNo: 0001493152-26-004289), reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing from the US market. No additional financial metrics, reasons for delisting, dollar values, or impacts were disclosed. This event signals a material regulatory compliance failure with no offsetting positive developments mentioned.

30-01-2026

Constellation Acquisition Corp I filed an 8-K on January 30, 2026, disclosing under Item 2.03 the creation of a direct financial obligation or off-balance sheet arrangement, under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, under Item 5.07 submission of matters to a vote of security holders, and under Item 9.01 financial statements and exhibits. No quantitative metrics, deal values, financial impacts, or specific transaction details are provided in the filing excerpt. No positive or negative performance metrics are mentioned.

30-01-2026

Flag Ship Acquisition Corp filed an 8-K on January 30, 2026, disclosing under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of the registrant. Item 9.01 includes financial statements and exhibits. No specific details on parties, amounts, terms, or context such as merger financing are provided.

30-01-2026

Myseum, Inc. filed a Form 8-K on January 30, 2026 (AccNo: 0001213900-26-009816, Size: 263 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, transactions, financial metrics, or exhibits are disclosed in the provided filing information. This is a multi-item filing with limited visibility into content.

30-01-2026

RICHTECH ROBOTICS INC. filed an 8-K on January 30, 2026, disclosing entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02. Item 8.01 reports other events, accompanied by financial statements and exhibits under Item 9.01. No specific transaction values, share counts, financial impacts, or detailed terms are disclosed.

30-01-2026

Chevron Corp filed an 8-K on January 30, 2026 (AccNo: 0000093410-26-000019, Size: 766 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This constitutes a multi-item filing for financial results disclosure. No specific quantitative financial metrics, period-over-period comparisons, guidance, or other numerical data are disclosed.

• ·Event Type: Financial Results
• ·Source: us_sec
• ·Sector: not specified

30-01-2026

Winvest Group Ltd filed an 8-K on January 30, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, or any quantitative impacts are disclosed. No positive or negative metrics are mentioned.

30-01-2026

Exxon Mobil Corp filed a Form 8-K on January 30, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 7.01 for Regulation FD disclosure. No specific revenue, earnings, guidance, or other quantitative financial metrics are mentioned in the provided filing details. This is a standard voluntary earnings-related disclosure with no directional performance data available.

30-01-2026

LyondellBasell Industries N.V. filed a Form 8-K on January 30, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, guidance, or other quantitative metrics are mentioned in the provided filing details. This represents a standard earnings announcement filing with no disclosed directional performance indicators.

30-01-2026

Aon plc filed a Form 8-K on January 30, 2026 (AccNo: 0001628280-26-004273), disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No quantitative financial metrics, period-over-period comparisons, revenue, earnings, guidance, or other specific numbers are provided in the filing details. This represents a standard earnings-related disclosure without directional performance indicators.

30-01-2026

Verizon Communications Inc. filed a Form 8-K on January 30, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. This multi-item filing pertains to financial results with no specific revenue, earnings, guidance, or period-over-period comparisons detailed in the provided information. No quantitative metrics, positive or negative performance indicators, or balance sheet effects are disclosed.

30-01-2026

Designer Brands Inc. filed a Form 8-K on January 30, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific names, positions affected, reasons for changes, timing details, or quantitative data such as compensation amounts are disclosed in the provided filing information. No financial metrics, performance comparisons, or other impacts are mentioned.

30-01-2026

SoFi Technologies, Inc. filed an 8-K on January 30, 2026, reporting Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits provided under Item 9.01. No quantitative financial metrics, revenue figures, earnings, period-over-period changes, guidance, or other specific performance data are disclosed in the filing details. This is an informational disclosure typical for earnings releases, but lacks details to assess positive or negative performance.

• ·AccNo: 0001818874-26-000008
• ·File Size: 1 MB
• ·Event Type: Financial Results

30-01-2026

Church & Dwight Co Inc /DE/ filed an 8-K on 2026-01-30 reporting results of operations and financial condition under Item 2.02 and financial statements and exhibits under Item 9.01. No quantitative financial metrics, period-over-period comparisons, guidance, or other specific data were explicitly disclosed in the provided filing information. Sector details were not specified.

30-01-2026

AMERICAN EXPRESS CO filed an 8-K on January 30, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a standard financial results disclosure, but no specific revenue, earnings, margins, guidance, or other quantitative metrics are disclosed in the provided filing information. All detailed financial data remains NOT_DISCLOSED.

30-01-2026

Atlantic Union Bankshares Corp filed a Form 8-K on January 30, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing represents a voluntary disclosure likely including attached materials such as a press release or investor presentation. No financial metrics, transactions, guidance, or other quantitative details are specified in the filing information provided.

30-01-2026

Immunocore Holdings plc filed an 8-K on 2026-01-30 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any quantitative impacts are disclosed.

30-01-2026

Air Products & Chemicals, Inc. filed an 8-K on January 30, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure.

30-01-2026

CHOICEONE FINANCIAL SERVICES INC filed an 8-K on January 30, 2026 (AccNo: 0001193125-26-030504, Size: 2 MB), categorized as an Officer Change event, disclosing under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific details on the officer position affected, appointment or resignation, reasons for change, financial metrics, period-over-period comparisons, or quantitative data are explicitly stated in the provided filing information. Sector is not specified, and no positive or negative performance indicators are mentioned.

30-01-2026

IES Holdings, Inc. filed a Form 8-K on January 30, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), disclosing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are mentioned in the provided filing summary. No positive or negative performance details, period-over-period comparisons, or strategic updates are disclosed.

30-01-2026

Colgate-Palmolive Co filed an 8-K on January 30, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 financial statements and exhibits. No specific revenue, earnings, margins, or period-over-period comparisons are detailed in the provided filing information. All quantitative financial metrics are NOT_DISCLOSED.

30-01-2026

Sierra Bancorp filed a Form 8-K on January 30, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the nature of the other events or contents of any exhibits are disclosed in the filing summary. This multi-item filing provides no quantitative metrics, financial impacts, or directional information.

30-01-2026

Coya Therapeutics, Inc. filed a Form 8-K on January 30, 2026 (AccNo: 0001193125-26-030531), reporting multiple items: Entry into a Material Definitive Agreement (Item 1.01), Unregistered Sales of Equity Securities (Item 3.02), Regulation FD Disclosure (Item 7.01), Other Events (Item 8.01), and Financial Statements and Exhibits (Item 9.01). This multi-item filing signals potentially significant developments, but no specific transaction details, financial metrics, dollar values, share counts, or impacts are disclosed in the provided information. No positive or negative quantitative metrics are available for balanced comparison.

30-01-2026

FIRST HAWAIIAN, INC. filed a Form 8-K on 2026-01-30 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, guidance, or other quantitative metrics were detailed in the provided filing information. This is an informational earnings-related disclosure with no directional financial impacts explicitly stated.

30-01-2026

Alpha Metallurgical Resources, Inc. filed a Form 8-K on January 30, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This constitutes a multi-item filing for financial results disclosure. No specific revenue, earnings, balance sheet metrics, period-over-period changes, or guidance details are disclosed in the provided filing information.

30-01-2026

Horizon Space Acquisition II Corp. filed an 8-K on 2026-01-30 disclosing other events under Item 8.01 and financial statements/exhibits under Item 9.01 in connection with a merger/acquisition event. No specific details on deal structure, parties involved, valuation, financial terms, synergies, regulatory pathway, or shareholder impacts are provided in the filing summary. No quantitative metrics, positive or negative performance indicators, or scheduled events are mentioned.

30-01-2026

Franklin Resources Inc filed an 8-K on January 30, 2026 (AccNo: 0000038777-26-000032, Size: 866 KB), reporting under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results as a voluntary earnings-related disclosure. No specific quantitative financial metrics, period-over-period comparisons, guidance, or other details are mentioned.

30-01-2026

ALX Oncology Holdings Inc filed a Form 8-K on January 30, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details of the other event, financial metrics, transactions, or impacts are disclosed in the provided filing summary. This is a multi-item filing with no quantitative data or period-over-period comparisons mentioned.

30-01-2026

WisdomTree, Inc. filed an 8-K on January 30, 2026, under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a multi-item filing announcing financial results, but detailed quantitative data is NOT_DISCLOSED.

• ·Filing Accession Number: 0001214659-26-000967
• ·Filing Size: 661 KB
• ·Sector: NOT_DISCLOSED

30-01-2026

Republic Bancorp Inc./KY/ filed an 8-K on January 30, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, guidance, or other quantitative metrics are mentioned in the provided filing information. This is a standard financial results disclosure with no directional performance indicators available.

30-01-2026

Leslie's, Inc. filed an 8-K on January 30, 2026, reporting a change in its certifying accountant under Item 4.01. The filing also includes financial statements and exhibits under Item 9.01. No specific details, such as the names of the prior or new accountants, reasons for the change, financial impacts, or quantitative metrics, are disclosed.

30-01-2026

Amgen Inc filed an 8-K on January 30, 2026, disclosing under Item 1.02 the termination of a material definitive agreement. Item 9.01 provides financial statements and exhibits. No specific details on the agreement, parties, financial impacts, or quantitative metrics are disclosed.

30-01-2026

Oppenheimer Holdings Inc. filed a Form 8-K on January 30, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, or period-over-period comparisons are detailed in the filing description. This appears to be a standard earnings-related disclosure without quantified metrics provided.

30-01-2026

Enzon Pharmaceuticals, Inc. filed an 8-K on January 30, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 3.03 material modifications to rights of security holders. Item 9.01 discloses financial statements and exhibits. No quantitative details, transaction values, or specific impacts are provided in the filing summary.

30-01-2026

ProMIS Neurosciences Inc. filed a Form 8-K on January 30, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 3.02 unregistered sales of equity securities, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. While the material agreement may represent a strategic development, the unregistered equity sales could imply potential shareholder dilution. No specific transaction details, financial impacts, or quantitative metrics are disclosed.

30-01-2026

Akebia Therapeutics, Inc. filed an 8-K on January 30, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 includes financial statements and exhibits. No specific details on transaction terms, financial impacts, or personnel changes are provided.

30-01-2026

ACM Research, Inc. filed a Form 8-K on January 30, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, or exhibits are disclosed. No quantitative metrics, positive or negative changes, or directional information are provided in the filing summary.

30-01-2026

Edible Garden AG Inc filed a Form 8-K on January 30, 2026 (AccNo: 0001477932-26-000522), reporting under Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing indicates governance and shareholder rights changes, but specific details on modifications, amendments, events, or exhibits are NOT_DISCLOSED. No quantitative financial impacts, positive or negative metrics, or directional biases are provided.

30-01-2026

Hudson Technologies Inc. (/NY) filed a Form 8-K on January 30, 2026 (AccNo: 0001104659-26-008337), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the events, transactions, financial metrics, or exhibits are disclosed in the filing summary. This appears to be a voluntary multi-item disclosure with no quantified impacts provided.

30-01-2026

Ultragenyx Pharmaceutical Inc. filed a Form 8-K on January 30, 2026, reporting under Item 8.01 Other Events (Accession No. 0001193125-26-030590, file size 155 KB). No specific details regarding the nature of the other event, financial impacts, transactions, or metrics are disclosed in the provided filing information. This appears to be a single-item voluntary disclosure.

30-01-2026

HERC Holdings Inc. filed an 8-K on January 30, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected (e.g., CEO, CFO), whether it was an appointment or resignation, reasons for the change (e.g., retirement, performance), internal/external status, timing, board composition impact, or any financial metrics were disclosed. This appears to be a routine governance disclosure with no quantified impacts provided.

30-01-2026

Cibus, Inc. filed a Form 8-K on January 30, 2026 (AccNo: 0001193125-26-030591, Size: 496 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary disclosure as Item 8.01 covers material events not specified in other items, with exhibits attached but details NOT_DISCLOSED. No financial metrics, transactions, or performance data are explicitly stated.

30-01-2026

RED RIVER BANCSHARES INC filed an 8-K on January 30, 2026, reporting results of operations and financial condition under Item 2.02. The filing includes financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, guidance, or other quantitative metrics were disclosed in the provided filing information.

30-01-2026

Actelis Networks Inc filed an 8-K on January 30, 2026 (AccNo: 0001213900-26-009889, Size: 214 KB), disclosing under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing for voluntary compliance with Regulation FD by publicly releasing material nonpublic information, with exhibits attached. No specific core event details, financial metrics, transactions, or quantitative impacts are disclosed.

30-01-2026

Wolfspeed, Inc. filed an 8-K on January 30, 2026, reporting under Item 5.02 regarding departure of directors or certain officers, election/appointment of directors/officers, and compensatory arrangements; Item 3.02 on unregistered sales of equity securities; Item 8.01 other events; and Item 9.01 financial statements/exhibits. No specific details on the officer change—including key position, appointment/resignation status, reasons, or timing—are disclosed. No quantitative metrics, financial data, named individuals, or scheduled events are mentioned.

30-01-2026

Nelnet Inc filed an 8-K on January 30, 2026, under Item 7.01 for Regulation FD Disclosure. No specific details, financial metrics, transactions, or other quantitative data were disclosed in the provided filing summary. No positive, negative, or flat performance metrics were mentioned.

30-01-2026

BKV Corp filed an 8-K on 2026-01-30 disclosing entry into a material definitive agreement under Item 1.01 and completion of an acquisition or disposition of assets under Item 2.01. The filing also covers unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). No specific parties, deal terms, financial metrics, positive or negative performance indicators, or quantitative data are disclosed in the provided filing information.

30-01-2026

Illumina, Inc. filed an 8-K on January 30, 2026, announcing the completion of an acquisition or disposition of assets under Item 2.01. The filing also includes other events under Item 8.01 and financial statements and exhibits under Item 9.01. No specific transaction details, parties, values, financial metrics, or performance comparisons are disclosed.

30-01-2026

Lottery.com Inc. filed a Form 8-K on January 30, 2026, reporting under Item 5.03 amendments to its Articles of Incorporation or Bylaws or a change in fiscal year. Item 9.01 discloses financial statements and exhibits, likely including the relevant documents. No specific details, quantitative impacts, positive or negative metrics, or directional changes are provided in the filing summary.

30-01-2026

Nuwellis, Inc. filed a multi-item Form 8-K on January 30, 2026, disclosing entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), material modifications to rights of security holders (Item 3.03), departures/elections/appointments of directors/officers and compensatory arrangements (Item 5.02), and Regulation FD disclosure (Item 7.01). No quantitative financial metrics, transaction values, share counts, or specific impacts are disclosed. The filing includes exhibits under Item 9.01.

30-01-2026

Ankam, Inc. filed an 8-K on 2026-01-30 under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits), with Accession Number 0001683168-26-000622 and file size of 210 KB. No specific core event details, financial metrics, transactions, or performance data (positive, negative, or flat) are disclosed in the provided filing information. This is a multi-item informational filing focused on compliant disclosure of material nonpublic information.

30-01-2026

Janus Henderson Group PLC filed an 8-K on January 30, 2026, under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, or period-over-period comparisons were detailed in the provided filing information. This appears to be a standard earnings-related disclosure without quantified metrics available.

30-01-2026

TOMPKINS FINANCIAL CORP filed an 8-K on January 30, 2026 (AccNo: 0001005817-26-000020), reporting Results of Operations and Financial Condition under Item 2.02, Other Events under Item 8.01, and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance revisions, period-over-period comparisons, or quantitative metrics were explicitly stated in the provided filing details. This multi-item filing pertains to financial results but lacks disclosed numerical data for performance assessment.

30-01-2026

AMERICAN AXLE & MANUFACTURING HOLDINGS INC filed an 8-K on January 30, 2026, disclosing amendments to its Articles of Incorporation or Bylaws or a change in fiscal year under Item 5.03, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details regarding the nature of the amendments, events, or exhibits are provided in the filing summary. No quantitative financial metrics, impacts, or period-over-period comparisons are mentioned.

30-01-2026

Starwood Real Estate Income Trust, Inc. filed a Form 8-K on January 30, 2026, reporting solely under Item 8.01 Other Events. No specific core event, transaction details, financial metrics, or quantitative impacts are disclosed in the provided filing information. This appears to be a single-item voluntary disclosure with Accession Number 0001193125-26-030655 and file size of 177 KB.

30-01-2026

STANDARD BIOTOOLS INC. filed an 8-K on January 30, 2026 (AccNo: 0001104659-26-008375), announcing the completion of an acquisition or disposition of assets under Item 2.01. The filing also discloses results of operations and financial condition (Item 2.02) and Regulation FD disclosure (Item 7.01), with financial statements and exhibits attached under Item 9.01. No specific transaction details, financial metrics, parties involved, or quantitative impacts are disclosed.

30-01-2026

SM Energy Co filed an 8-K on 2026-01-30 disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). The filing also covers creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), amendments to articles of incorporation or bylaws and/or change in fiscal year (Item 5.03), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No quantitative deal terms, parties involved, or financial impacts were explicitly stated.

30-01-2026

Ondas Holdings Inc. filed an 8-K on January 30, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific events, transactions, financial metrics, or quantitative data are disclosed in the filing metadata. No positive or negative metrics reported.

30-01-2026

BLACKSTAR ENTERPRISE GROUP, INC. filed a Form 8-K on January 30, 2026, disclosing changes in its certifying accountant under Item 4.01, which is a material event often associated with potential accounting or governance concerns. The filing also references Item 9.01 for financial statements and exhibits, likely including related documentation. No quantitative financial metrics, transaction details, or further specifics on the change are disclosed.

30-01-2026

Security Federal Corp filed an 8-K on January 30, 2026, disclosing Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, or other quantitative financial metrics are mentioned. No positive, negative, or flat performance indicators are provided.

30-01-2026

Protalix BioTherapeutics, Inc. filed an 8-K on January 30, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, transaction values, financial metrics, or exhibits are provided in the filing summary. This appears to be a multi-item informational filing with no quantified impacts disclosed.

30-01-2026

FIRST FINANCIAL CORP /IN/ filed an 8-K on January 30, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, transactions, events, or quantitative data are disclosed in the provided filing information. This appears to be a voluntary disclosure with attached exhibits, but details are NOT_DISCLOSED.

30-01-2026

MetroCity Bankshares, Inc. filed a Form 8-K on January 30, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, or other quantitative financial metrics, period-over-period comparisons, or guidance are disclosed in the provided filing details. This appears to be a standard earnings-related disclosure without detailed performance data available.

30-01-2026

OptimumBank Holdings, Inc. filed an 8-K on January 30, 2026, disclosing entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, with financial statements and exhibits under Item 9.01. No specific details, dollar values, share counts, or financial impacts are disclosed in the provided filing summary. This is a multi-item mandatory filing signaling potentially significant corporate actions, but lacks quantitative data for assessment.

30-01-2026

SOURCE CAPITAL /DE/ filed an 8-K on January 30, 2026, disclosing Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01. No specific details regarding the nature of the events, transactions, financial metrics, or exhibits are disclosed in the provided filing information.

30-01-2026

Hypha Labs, Inc. filed an 8-K on January 30, 2026, disclosing changes in its certifying accountant under Item 4.01. The filing also references financial statements and exhibits under Item 9.01. No additional quantitative data, reasons for the change, financial impacts, or other metrics are explicitly stated.

30-01-2026

Flowco Holdings Inc. filed an 8-K on January 30, 2026, under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific events, transactions, financial metrics, or quantitative data are disclosed in the provided filing information. The disclosure likely includes material nonpublic information and attached exhibits, but details are NOT_DISCLOSED.

30-01-2026

Spark I Acquisition Corp filed an 8-K on January 30, 2026 (AccNo: 0001104659-26-008449), under Item 3.01, disclosing a notice of delisting or failure to satisfy a continued listing rule or standard; transfer of listing. No quantitative financial metrics, transaction details, deal structure, parties involved, valuations, synergies, regulatory pathways, or shareholder impacts are mentioned. Sector is not specified, and no positive or comparative performance data is provided.

30-01-2026

Lion Copper & Gold Corp. filed an 8-K on January 30, 2026 (AccNo: 0001062993-26-000493, size: 242 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This indicates a voluntary disclosure of material nonpublic information with attached exhibits, but no specific details, metrics, transactions, or events are provided in the filing summary. No quantitative financial data, guidance, or operational updates are disclosed.

30-01-2026

Cullen/Frost Bankers, Inc. filed an 8-K on January 30, 2026, disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the affected officer, position, reason, timing, or any quantitative data are disclosed in the provided filing summary.

30-01-2026

International Endeavors Corp filed a Form 8-K on January 30, 2026, disclosing entry into a material definitive agreement under Item 1.01, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details on the agreement's nature, parties, terms, or financial impacts provided. No quantitative metrics, positive or negative changes, or period-over-period comparisons are disclosed.

30-01-2026

1ST SOURCE CORP filed an 8-K on January 30, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the Regulation FD disclosure content, financial metrics, transactions, guidance, or exhibits are provided in the filing summary. This appears to be a voluntary, multi-item informational filing with no quantified positive or negative impacts disclosed.

30-01-2026

Sky Century Investment, Inc. filed an 8-K on January 30, 2026, reporting material modifications to rights of security holders under Item 3.03, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This is a multi-item filing with no specific details on the nature of the modifications, events, or exhibits provided. No quantitative financial metrics, impacts, or comparisons are disclosed.

30-01-2026

PROCACCIANTI HOTEL REIT, INC. filed a Form 8-K on January 30, 2026 (AccNo: 0001104659-26-008505), reporting an Other Event under Item 8.01. No specific details regarding the nature of the event, financial metrics, transactions, or impacts are disclosed in the filing summary. This appears to be a single-item voluntary disclosure with no quantitative data provided.

30-01-2026

SmartKem, Inc. filed an 8-K on 2026-01-30 disclosing under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No quantitative details, transaction terms, financial impacts, or other metrics are provided in the filing summary. This represents a multi-item mandatory disclosure with limited specifics available.

30-01-2026

Caro Holdings Inc. filed an 8-K on January 30, 2026 (AccNo: 0001640334-26-000176, Size: 121 KB), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the key position affected, individuals involved, reasons for the change, timing, or any quantitative data such as compensation are disclosed. Sector is NOT_DISCLOSED.

• ·Event date: January 30, 2026
• ·Source: us_sec

30-01-2026

International Land Alliance Inc. filed a Form 8-K on January 30, 2026, reporting multiple material events under Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), and Item 3.02 (Unregistered Sales of Equity Securities), with Item 9.01 listing Financial Statements and Exhibits. No quantitative details such as transaction values, share counts, or financial impacts are disclosed in the provided information. This multi-item filing signals potentially significant corporate actions but lacks specifics on positive or negative implications.

• ·Multi-item 8-K filing indicating mandatory disclosures for material agreement, financial obligation, and equity securities sales
• ·AccNo: 0001493152-26-004441, Size: 432 KB
• ·Sector: NOT_DISCLOSED

30-01-2026

Lendway, Inc. filed a Form 8-K on January 30, 2026, reporting under Item 5.03 amendments to its Articles of Incorporation or Bylaws or a change in fiscal year, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. No specific details, numerical values, positive or negative metrics, or transaction sizes are disclosed in the filing summary. This is a multi-item informational filing with no quantified impacts provided.

30-01-2026

CSG Systems International Inc filed an 8-K on January 30, 2026, specifically under Item 5.07, disclosing the submission of matters to a vote of security holders following a shareholder meeting. No vote results, proposals, share counts, or other quantitative details are mentioned in the provided filing information. This is purely informational with no financial metrics or directional implications disclosed.

30-01-2026

Cincinnati Financial Corp filed an 8-K on 2026-01-30 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the officer involved, position affected, reason for change, or timing are provided. No quantitative financial metrics, performance comparisons, or other numerical data are mentioned.

30-01-2026

Cannabist Co Holdings Inc. filed an 8-K on January 30, 2026, reporting under Item 8.01 Other Events. No specific event details, financial metrics, transaction values, or other quantitative data are disclosed in the provided filing information.

30-01-2026

Tevogen Bio Holdings Inc. filed an 8-K on January 30, 2026 (AccNo: 0001493152-26-004461, size 277 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing likely involving voluntary disclosure of material information and attached exhibits, such as a press release. No quantitative metrics, transactions, or performance data—positive, negative, or flat—are disclosed in the filing summary.

30-01-2026

NRG Energy, Inc. filed an 8-K on January 30, 2026, disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). The filing also includes creation of a direct financial obligation (Item 2.03), unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements/exhibits (Item 9.01). No specific deal terms, parties, values, positives, negatives, or metrics were disclosed.

30-01-2026

FG Imperii Acquisition Corp. filed an 8-K on 2026-01-30 disclosing entry into a material definitive agreement under Item 1.01. Item 9.01 provides financial statements and exhibits. No quantitative metrics, transaction details, parties, valuation, or performance comparisons (positive, negative, or flat) are disclosed in the provided filing summary.

30-01-2026

Power Integrations Inc filed an 8-K on 2026-01-30 disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers; under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year; and under Item 9.01 financial statements and exhibits. No specific details such as names, positions, reasons for changes, or quantitative impacts are disclosed. No positive or negative metrics are provided in the filing summary.

30-01-2026

Mondelez International, Inc. filed an 8-K on January 30, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, reason for change, or any quantitative impacts were disclosed.

30-01-2026

PEOPLES FINANCIAL SERVICES CORP. filed an 8-K on January 30, 2026, disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the officer involved, position affected, reason for change, or any quantitative metrics are disclosed.

30-01-2026

Surrozen, Inc./DE filed an 8-K on 2026-01-30 under Item 5.02 disclosing matters related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details, names, reasons, timing, or financial terms are provided in the filing summary. Sector not specified.

30-01-2026

Kelly Services Inc filed a multi-item Form 8-K on January 30, 2026 (AccNo: 0001193125-26-031768), reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or Off-Balance Sheet Arrangement), Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.01 (Changes in Control of Registrant), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific transaction details, dollar values, named parties, quantitative metrics, or period-over-period comparisons are disclosed in the provided filing information.

30-01-2026

Senmiao Technology Ltd filed a Form 8-K on January 30, 2026, under Item 8.01 disclosing Other Events. No specific details regarding the nature of the events, financial impacts, quantitative metrics, or other material information are provided in the filing metadata. This appears to be a voluntary informational disclosure with no extracted numbers or comparisons.

30-01-2026

Olema Pharmaceuticals, Inc. filed an 8-K on 2026-01-30 disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. Specific details such as the affected officer's name, position, whether it was an appointment or resignation, reasons, or effective date are NOT_DISCLOSED.

30-01-2026

Blue Foundry Bancorp filed a Form 8-K on January 30, 2026, reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No specific details regarding the matters submitted, meeting date, proposals, vote outcomes, or tallies are disclosed in the available filing summary. This represents a standard mandatory disclosure for shareholder voting results.

30-01-2026

Genasys Inc. filed an 8-K on January 30, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, or financial terms are disclosed in the provided filing summary. No quantitative metrics, performance comparisons, or additional context provided.

30-01-2026

BranchOut Food Inc. filed a Form 8-K on January 30, 2026, disclosing multiple material events under Items 1.01 (Entry into a Material Definitive Agreement), 2.02 (Results of Operations and Financial Condition), 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing covering a new agreement, financial results, and new financial obligations, but specific transaction details, dollar values, financial metrics, or performance comparisons are NOT_DISCLOSED. No positive or negative metrics, period-over-period changes, or guidance revisions are provided in the available information.

30-01-2026

Athena Technology Acquisition Corp. II filed an 8-K on January 30, 2026, under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits) in connection with a merger/acquisition event. No quantitative metrics, deal structure details, parties involved, strategic rationale, or financial impacts were explicitly disclosed in the provided filing summary. Sector remains unspecified.

30-01-2026

INVO Fertility, Inc. filed a multi-item Form 8-K on January 30, 2026, reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, alongside other events (Item 8.01) and exhibits (Item 9.01). While the material agreement suggests potential strategic developments, the unregistered equity sales indicate possible shareholder dilution. No specific transaction details, financial metrics, or dollar values were disclosed.

30-01-2026

Yellowstone Midco Holdings II, LLC filed a Form 8-K on January 30, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 3.03 material modifications to rights of security holders, Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers, Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, and Item 9.01 financial statements and exhibits. No quantitative financial metrics, transaction values, named individuals, or specific details on the events were disclosed. This multi-item filing indicates significant governance and contractual changes without disclosed positive or negative impacts.

• ·Multi-item mandatory 8-K filing covering governance changes and a material agreement.
• ·No revenue, earnings, balance sheet effects, guidance, or dollar values disclosed.
• ·Critical missing information: Specific details of the material definitive agreement, identities of departing/appointed directors/officers, nature of rights modifications or amendments, any financial exhibits content, dollar value or size of transaction, period-over-period metrics. Analysis confidence: LOW (<50% key data available).

30-01-2026

Design Therapeutics, Inc. filed an 8-K on January 30, 2026 (AccNo: 0001193125-26-031772), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the key position affected, individuals involved, appointment or resignation status, reasons, or impacts are disclosed. Sector is NOT_DISCLOSED.

30-01-2026

SPLASH BEVERAGE GROUP, INC. filed a Form 8-K on January 30, 2026 (AccNo: 0001731122-26-000156, Size: 187 KB), reporting under Item 3.02 regarding unregistered sales of equity securities. No quantitative details such as transaction value, share count, dollar amounts, or parties involved are disclosed in the available filing information. This is a single-item mandatory disclosure typically related to exempt equity issuances under the Securities Act.

30-01-2026

Beeline Holdings, Inc. filed an 8-K on 2026-01-30 reporting under Item 1.01 entry into a material definitive agreement, under Item 3.02 unregistered sales of equity securities, and under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year. Item 9.01 discloses financial statements and exhibits. No quantitative financial metrics, transaction values, or performance comparisons are provided in the filing summary.

30-01-2026

OmniAb, Inc. filed an 8-K on January 30, 2026, disclosing amendments to its Articles of Incorporation or Bylaws, or a change in fiscal year under Item 5.03, with financial statements and exhibits attached under Item 9.01. No specific details on the nature or impact of the amendments are provided in the filing summary. No quantitative financial metrics, changes, or directional impacts are mentioned.

30-01-2026

Robinhood Markets, Inc. filed a Form 8-K on January 30, 2026, disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics were provided in the filing description. This appears to be a standard voluntary earnings release filing with attached materials, but detailed performance data is NOT_DISCLOSED.

30-01-2026

Generation Income Properties, Inc. filed a Form 8-K on January 30, 2026, reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No financial metrics, transaction values, dollar impacts, or additional details such as reasons for delisting, balance sheet effects, or guidance changes are disclosed.

30-01-2026

Selective Insurance Group Inc filed a Form 8-K on January 30, 2026, disclosing under Item 5.03 amendments to its Articles of Incorporation or Bylaws or a change in fiscal year, accompanied by Item 9.01 for financial statements and exhibits. No specific details on the nature, scope, or implications of the amendments or changes were provided, and no quantitative financial impacts were mentioned. This is a multi-item informational filing with no evident positive or negative metrics.

30-01-2026

Slam Corp. filed a Form 8-K on January 30, 2026, reporting solely under Item 8.01 Other Events, with accession number 0001213900-26-010169 and file size of 247 KB. No specific details about the event, transaction, financial metrics, positive developments, negative impacts, or flat performance are disclosed. This is a voluntary disclosure category with no quantitative data provided.

30-01-2026

Direct Digital Holdings, Inc. filed a Form 8-K on January 30, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific transaction details, dollar values, terms, or financial impacts are disclosed.

30-01-2026

Dollar Tree, Inc. filed an 8-K on January 30, 2026 (AccNo: 0000935703-26-000017), disclosing developments under Item 5.02 related to departure of directors or certain officers, election or appointment of directors or certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, nature of changes (appointment or resignation), reasons, or any quantitative impacts are disclosed. This appears to be a routine governance disclosure with no additional financial or operational metrics provided.

30-01-2026

TuHURA Biosciences, Inc./NV filed a Form 8-K on January 30, 2026 (AccNo: 0001193125-26-031742), under Item 3.01, providing notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No quantitative financial metrics, positive developments, or additional details such as reasons, impacts, or timelines were disclosed. This represents a material negative event with no offsetting positives mentioned.

• ·Filing size: 167 KB
• ·Sector: not specified

30-01-2026

Kingstone Companies, Inc. filed a Form 8-K on January 30, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific core event, transaction details, financial metrics, or quantitative data are disclosed in the provided filing information. The filing size is 164 KB, suggesting attachments, but content details are NOT_DISCLOSED.

30-01-2026

NATIONAL RURAL UTILITIES COOPERATIVE FINANCE CORP /DC/ filed a Form 8-K on January 30, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, events, transaction size, parties, financial impacts, or metrics disclosed in the provided information. No positive or negative quantitative changes are mentioned.

30-01-2026

Solo Brands, Inc. filed an 8-K on 2026-01-30 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for changes, or any financial metrics are disclosed in the provided filing summary. No positive or negative metrics are mentioned.

30-01-2026

Becton Dickinson & Co filed a Form 8-K on January 30, 2026, disclosing matters under Item 5.02 related to departure of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements of certain officers. The filing also covers Item 5.07 on submission of matters to a vote of security holders and Item 9.01 on financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for changes, voting outcomes, or exhibits are disclosed in the provided information.

30-01-2026

Archimedes Tech SPAC Partners III Co. filed an 8-K on January 30, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, financial statements, or exhibits are disclosed in the provided filing information. No quantitative metrics, transactions, or scheduled events are mentioned.

30-01-2026

PEDEVCO CORP filed an 8-K on 2026-01-30 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, names, reasons for change, timing, or compensation arrangements are provided. No quantitative financial metrics, performance comparisons, or other material data are mentioned.

30-01-2026

Microvision, Inc. filed a Form 8-K on January 30, 2026 (AccNo: 0001493152-26-004505), reporting under Item 1.01 entry into a material definitive agreement, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. This is a multi-item filing with no specific details on the agreement, transaction terms, financial impacts, quantitative metrics, or other data explicitly stated. No positive, negative, or flat performance metrics are disclosed.

30-01-2026

Spire Inc filed an 8-K on January 30, 2026, under Item 5.07 disclosing the submission of matters to a vote of security holders, likely from an annual or special shareholder meeting. Item 9.01 references financial statements and exhibits. No specific proposals, vote outcomes, numerical results, or other metrics are disclosed.

30-01-2026

RadNet, Inc. filed an 8-K on January 30, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of the financial statements and exhibits are disclosed. This is an informational filing with no quantitative metrics, comparisons, or directional impacts provided.

30-01-2026

NEW PEOPLES BANKSHARES INC filed an 8-K on January 30, 2026, under Item 2.02 reporting Results of Operations and Financial Condition, and Item 9.01 for Financial Statements and Exhibits. This is a standard financial results disclosure for the company in the US market. No specific revenue, earnings, balance sheet details, period-over-period comparisons, guidance, or other quantitative metrics are disclosed.

30-01-2026

ONITY GROUP INC. filed a Form 8-K on January 30, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details regarding the content of the disclosure, financial metrics, transactions, or exhibits are provided in the filing metadata. This is a multi-item filing likely involving voluntary disclosure of material information.

30-01-2026

LM Funding America, Inc. filed a Form 8-K on January 30, 2026, under Item 2.03 disclosing the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of the registrant. Item 9.01 provides for financial statements and exhibits. No transaction details, dollar values, or financial impacts are disclosed.

30-01-2026

SB Financial Group, Inc. filed an 8-K on January 30, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This is an informational earnings-related disclosure with no directional data available for analysis.

30-01-2026

X3 Acquisition Corp. Ltd. filed an 8-K on 2026-01-30 disclosing unregistered sales of equity securities under Item 3.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No quantitative metrics, deal details, parties involved, valuations, synergies, regulatory pathways, or shareholder impacts are explicitly stated in the provided filing summary. Sector is not specified.

30-01-2026

Esquire Financial Holdings, Inc. filed an 8-K on 2026-01-30 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, names, reasons for change, timing, or financial metrics are disclosed.

30-01-2026

FIRST ADVANTAGE CORP filed an 8-K on January 30, 2026 (AccNo: 0001193125-26-031830, Size: 150 KB), disclosing information under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on affected positions, individuals involved, reasons for change, timing, or any quantitative impacts are disclosed. Sector is not specified.

30-01-2026

Blackstone Real Estate Income Trust, Inc. filed a Form 8-K on January 30, 2026, reporting under Item 7.01 for Regulation FD Disclosure. No specific financial metrics, transactions, or operational details are disclosed in the provided filing information. This is a single-item voluntary disclosure with no quantitative data or period-over-period comparisons mentioned.

30-01-2026

Pioneer Bancorp, Inc./MD filed an 8-K on January 30, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet metrics, period-over-period changes, guidance, or other quantitative financial data are disclosed in the filing summary. This represents a standard voluntary earnings-related disclosure with attached exhibits.

30-01-2026

Marchex Inc filed an 8-K on 2026-01-30 disclosing Item 1.01 Entry into a Material Definitive Agreement alongside Item 5.02 regarding Departure of Directors or Certain Officers, Election of Directors, Appointment of Certain Officers, and Compensatory Arrangements of Certain Officers. This is a multi-item filing with no specific details on the agreement terms, personnel involved, or financial implications provided. No quantitative metrics, positive or negative changes, or period-over-period comparisons are mentioned.

30-01-2026

OPENLANE, Inc. filed a Form 8-K on January 30, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, appointment or resignation status, reasons for the change, timing, or individuals involved are disclosed. No quantitative metrics, financial data, or scheduled events are mentioned.

30-01-2026

BCB BANCORP INC filed an 8-K on 2026-01-30 (AccNo: 0001193125-26-031836) reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a standard multi-item filing for financial results disclosure, likely including a press release or earnings exhibits. No specific revenue, earnings, margins, balance sheet changes, period-over-period comparisons, guidance, or other quantitative metrics are disclosed in the provided filing information.

30-01-2026

Velocity Financial, Inc. filed an 8-K on January 30, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 8.01 other events, with Item 9.01 listing financial statements and exhibits. No specific details on the agreement, events, dollar values, financial impacts, or performance metrics are disclosed in the provided filing summary. No positive or negative metrics, period-over-period comparisons, or quantitative data are mentioned.

30-01-2026

RCI Hospitality Holdings, Inc. filed a Form 8-K on January 30, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of the financial statements and exhibits are disclosed in the provided filing information. No quantitative financial metrics, positive or negative changes, or performance comparisons are mentioned.

30-01-2026

Zillow Group, Inc. filed an 8-K on January 30, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. No quantitative details such as transaction value, financial terms, or impact on revenue, earnings, or balance sheet were disclosed. This is a multi-item mandatory filing with no additional metrics, guidance changes, or scheduled events mentioned.

30-01-2026

Skyworks Solutions, Inc. filed a Form 8-K on January 30, 2026, reporting under Item 8.01 Other Events. The filing accession number is 0001104659-26-008644 and file size is 262 KB. No specific details on the event, financial metrics, transactions, or impacts are disclosed.

30-01-2026

Laird Superfood, Inc. filed an 8-K on January 30, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 lists financial statements and exhibits. No specific details, dollar values, personnel names, or financial impacts are disclosed.

30-01-2026

Dragonfly Energy Holdings Corp. filed an 8-K on January 30, 2026, reporting entry into a material definitive agreement under Item 1.01 and attaching financial statements and exhibits under Item 9.01. No specific details on the agreement, transaction value, parties, or financial impacts are disclosed. This is a multi-item filing focused on a material event with no quantitative metrics provided.

30-01-2026

ARTELO BIOSCIENCES, INC. filed an 8-K on January 30, 2026, reporting under Item 5.07: Submission of Matters to a Vote of Security Holders, indicating results from a shareholder meeting were disclosed. No specific matters voted on, vote outcomes, numerical results, or other metrics are mentioned in the provided filing details. This is a single-item mandatory filing with no financial or operational impacts explicitly stated.

30-01-2026

VYNE Therapeutics Inc. filed an 8-K on January 30, 2026, reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 discloses financial statements and exhibits. No specific details on the agreement terms, parties, financial impacts, or quantitative metrics are provided in the filing summary.

30-01-2026

Cedar Realty Trust, Inc. filed a Form 8-K on January 30, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details on the disclosure content, financial metrics, transactions, or events are provided in the filing summary.

30-01-2026

Intuit Inc. filed an 8-K on January 30, 2026 (AccNo: 0000896878-26-000008, Size: 887 KB), disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of the registrant. Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, terms, strategic context, or financial metrics are disclosed in the provided filing summary.

30-01-2026

AXIS Capital Holdings Ltd filed an 8-K on 2026-01-30 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for the change, timing, or any quantitative data such as compensation amounts are provided in the filing summary. This is a standard governance disclosure with no indicated positive or negative performance metrics.

30-01-2026

Walmart Inc. filed an 8-K on 2026-01-30 under Item 5.02 disclosing a change involving departure of directors or certain officers, election or appointment of directors or certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individuals involved, reasons for the change, or any quantitative impacts are disclosed. No positive or negative metrics are provided in the filing summary.

30-01-2026

Strawberry Fields REIT, Inc. filed an 8-K on January 30, 2026, disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, elections of directors, appointments of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on the affected officer, position, reason for change, or effective date are disclosed.

30-01-2026

CCC Intelligent Solutions Holdings Inc. filed a Form 8-K on January 30, 2026 (AccNo: 0001193125-26-031802, Size: 172 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses material nonpublic information voluntarily to comply with Regulation FD, with exhibits attached, but no specific details, financial metrics, transactions, or events are provided in the filing summary. No quantitative data or performance metrics (positive, negative, or flat) are mentioned.

30-01-2026

Federated Hermes, Inc. filed a Form 8-K on January 30, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of any attached financial statements or exhibits are disclosed in the provided filing summary. This is a multi-item filing with no quantified financial metrics, positive or negative changes, or directional impacts mentioned.

30-01-2026

Expion360 Inc. filed a Form 8-K on 2026-01-30 under Item 3.01 announcing a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No financial metrics, positive developments, dollar values, or reasons for the delisting were disclosed. This represents a material negative event with no offsetting positives mentioned.

• ·Accession Number: 0001903596-26-000022
• ·Filing size: 202 KB
• ·Sector: NOT_DISCLOSED

30-01-2026

Aditxt, Inc. filed a Form 8-K on January 30, 2026 (AccNo: 0001213900-26-010217, Size: 195 KB), reporting solely under Item 8.01 Other Events. No specific details regarding the nature of the other events, financial metrics, transactions, or impacts are disclosed in the provided filing information. No quantitative data, period-over-period comparisons, or named entities beyond the filer are mentioned.

30-01-2026

AB International Group Corp. filed an 8-K on January 30, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement, and under Item 3.02 unregistered sales of equity securities. Item 9.01 provides financial statements and exhibits. No quantitative details such as transaction values, share counts, financial impacts, or period-over-period comparisons are disclosed.

30-01-2026

CAPITAL SOUTHWEST CORP filed an 8-K on 2026-01-30 disclosing information under Item 7.01 Regulation FD Disclosure and listing exhibits under Item 9.01 Financial Statements and Exhibits. This is a multi-item filing likely involving voluntary disclosure of material information to comply with Regulation FD, with attached documents. No specific transactions, financial metrics, or operational details are disclosed.

30-01-2026

GigCapital9 Corp. filed a Form 8-K on January 30, 2026, disclosing multiple events including entry into a material definitive agreement (Item 1.01), unregistered sales of equity securities (Item 3.02), departures or appointments of directors/officers and compensatory arrangements (Item 5.02), and amendments to articles of incorporation or bylaws (Item 5.03), along with other events (Item 8.01) and exhibits (Item 9.01). No specific transaction details, financial impacts, or quantitative metrics are disclosed in the provided filing summary. This multi-item filing signals potential strategic, governance, and capital structure changes, but lacks details to assess directionality.

30-01-2026

USCB Financial Holdings, Inc. filed an 8-K on 2026-01-30 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or quantitative data are disclosed.

30-01-2026

Kennametal Inc filed an 8-K on January 30, 2026 (AccNo: 0001628280-26-004395, Size: 205 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events or the nature of the financial statements and exhibits are disclosed. No quantitative metrics, positive or negative changes, or directional impacts are mentioned.

30-01-2026

30-01-2026

IMAC Holdings, Inc. filed an 8-K on 2026-01-30 disclosing entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, accompanied by financial statements and exhibits under Item 9.01. This is a multi-item mandatory filing with no specific transaction details, dollar values, or impacts provided. No positive or negative financial metrics, comparisons, or guidance changes are mentioned.

30-01-2026

Byrna Technologies Inc. filed an 8-K on 2026-01-30 (AccNo: 0001437749-26-002563) under Item 5.02 disclosing departure of directors or certain officers; election of directors; appointment of certain officers; and compensatory arrangements of certain officers. No specific details on key positions affected (e.g., CEO, CFO), whether appointment or resignation, reasons for change, internal/external status, timing, or any quantitative data such as compensation amounts are disclosed. No board meeting outcomes, succession signals, financial metrics, or scheduled events mentioned.

30-01-2026

IF Bancorp, Inc. filed a Form 8-K on January 30, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This multi-item filing provides disclosure of financial results but no specific metrics, comparisons, or performance details are stated in the provided information. No positive, negative, or flat metrics are disclosed.

30-01-2026

International Business Machines Corp (IBM) filed an 8-K on January 30, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on the affected officer, position, reason for change, timing, or any quantitative impacts are disclosed.

30-01-2026

PPL Corp filed an 8-K on January 30, 2026, under Item 2.03 disclosing the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of the registrant. The filing also covers Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No quantitative details such as transaction values, terms, or financial impacts are disclosed.

30-01-2026

Quetta Acquisition Corp filed an 8-K on January 30, 2026, disclosing under Item 1.01 entry into a new material definitive agreement and under Item 1.02 termination of a prior material definitive agreement, signaling a pivot in merger/acquisition strategy. No quantitative metrics, deal values, parties involved, or financial impacts are disclosed, resulting in mixed implications with no clear positive or negative dominance. Sector details are not specified.

30-01-2026

Arrive AI Inc. filed an 8-K on January 30, 2026, reporting Item 1.01 Entry into a Material Definitive Agreement and Item 3.02 Unregistered Sales of Equity Securities, with Item 9.01 Financial Statements and Exhibits. No specific transaction details, dollar values, parties, strategic rationale, or financial impacts are disclosed. This is a multi-item mandatory filing with no quantitative metrics provided.

30-01-2026

FUSE GROUP HOLDING INC. filed an 8-K on January 30, 2026, reporting entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, with financial statements and exhibits under Item 9.01. No specific transaction details, dollar values, strategic context, or financial impacts are disclosed. This is a multi-item mandatory filing with no quantitative metrics provided.

30-01-2026

NovaBay Pharmaceuticals, Inc. filed an 8-K on January 30, 2026, disclosing changes in its certifying accountant under Item 4.01 and other events under Item 8.01. No financial metrics, transaction values, period-over-period comparisons, or impacts are mentioned. This is a multi-item filing with no quantified positive or negative details provided.

30-01-2026

NanoVibronix, Inc. filed a Form 8-K on January 30, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 3.03 material modifications to rights of security holders, and under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year. Item 9.01 includes financial statements and exhibits. No quantitative details, transaction values, financial impacts, or specific terms are disclosed in the provided filing summary.

30-01-2026

Legato Merger Corp. IV filed an 8-K on 2026-01-30 (AccNo: 0001829126-26-000821) disclosing Item 3.02 Unregistered Sales of Equity Securities, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits in connection with a merger/acquisition event. No specific deal structure, parties, valuation, financial metrics, synergies, regulatory details, or shareholder impacts are mentioned. Sector is not specified, and no quantitative data or comparisons are provided.

30-01-2026

Rithm Acquisition Corp. filed an 8-K on 2026-01-30 disclosing Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. Item 9.01 includes Financial Statements and Exhibits. No quantitative metrics, transaction details, or period-over-period comparisons are mentioned.

30-01-2026

PennantPark Investment Corp filed an 8-K on January 30, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No quantitative details, transaction values, or impacts are disclosed in the provided filing summary.

30-01-2026

Carter Bankshares, Inc. filed an 8-K on January 30, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing likely involving voluntary disclosure of material nonpublic information with attached supporting documents. No specific financial metrics, transactions, or quantitative data are disclosed.

30-01-2026

BioAtla, Inc. filed a multi-item Form 8-K on January 30, 2026, disclosing amendments to articles of incorporation or bylaws/change in fiscal year under Item 5.03, submission of matters to a vote of security holders under Item 5.07, Regulation FD disclosure under Item 7.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details, outcomes, or financial metrics from these items are provided in the filing summary. This appears to be an informational governance and disclosure filing with no quantified positive or negative impacts mentioned.

30-01-2026

Beta Bionics, Inc. filed a Form 8-K on January 30, 2026 (AccNo: 0001171843-26-000538, Size: 190 KB), reporting solely under Item 8.01 Other Events. No specific details regarding the core event, financial metrics, transactions, or quantitative data are explicitly stated in the provided filing information. This appears to be a single-item, voluntary disclosure with no mentioned positive or negative developments.

30-01-2026

AGCO Corp filed an 8-K on January 30, 2026, reporting solely under Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the financial statements, exhibits, transactions, metrics, or events are disclosed in the provided filing information. This is an informational exhibit attachment with no quantitative data or directional implications provided.

30-01-2026

Marquie Group, Inc. filed an 8-K on 2026-01-30 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any quantitative data were provided in the filing summary. No positive or negative metrics were mentioned.

30-01-2026

IO Biotech, Inc. filed an 8-K on January 30, 2026, disclosing costs associated with exit or disposal activities under Item 2.05, departure of directors or certain officers, election or appointment of directors/officers, and compensatory arrangements under Item 5.02, other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on leadership changes, reasons, costs, or metrics are disclosed in the provided information.

30-01-2026

Comstock Inc. filed an 8-K on January 30, 2026, reporting entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02, alongside Regulation FD disclosure under Item 7.01 and exhibits under Item 9.01. No specific transaction details, dollar values, share counts, or financial impacts are disclosed in the provided filing summary. This multi-item filing signals potentially strategic developments but also possible dilution from equity sales.

30-01-2026

FIRST KEYSTONE CORP filed an 8-K on January 30, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific revenue, earnings, balance sheet details, period-over-period comparisons, or other quantitative metrics in the available summary. No positive, negative, or flat performance indicators are mentioned.

30-01-2026

Tenaya Therapeutics, Inc. filed an 8-K on 2026-01-30 reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, which is a material negative event signaling potential loss of exchange listing and reduced liquidity. Item 5.02 discloses departures of directors or certain officers, elections, appointments, or compensatory arrangements, with unspecified direction that could indicate leadership changes but lacks positive or negative details. Item 9.01 includes financial statements and exhibits, providing additional context without specified metrics.

30-01-2026

Saratoga Investment Corp. filed a Form 8-K on 2026-01-30 reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific details, dollar values, terms, positive or negative impacts, or other metrics are provided in the filing summary.

30-01-2026

EQV Ventures Acquisition Corp. filed an SEC document on 2026-01-30 (AccNo: 0001213900-26-010279, Size: 48 MB) related to a Merger/Acquisition event. No specific details on parties, deal structure, valuation, financial terms, synergies, regulatory pathway, shareholder impacts, or market implications are disclosed in the provided metadata. Sector is not specified, limiting assessment of strategic rationale or sector effects.

30-01-2026

Aspire Biopharma Holdings, Inc. filed an 8-K on January 30, 2026 (AccNo: 0001493152-26-004543), reporting under Item 1.01 entry into a material definitive agreement and under Item 3.02 unregistered sales of equity securities, with Item 9.01 providing financial statements and exhibits. This constitutes a multi-item mandatory disclosure with no quantitative details on transaction values, share counts, or financial impacts provided. No positive or negative metrics are disclosed.

30-01-2026

Stardust Power Inc. filed an 8-K on January 30, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, or any quantitative data are NOT_DISCLOSED. No positive or negative metrics, board outcomes, or governance implications are specified.

30-01-2026

OFF THE HOOK YS INC. filed an 8-K on January 30, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific names, positions affected, reasons for changes, or quantitative details were provided in the filing summary. No financial metrics, performance comparisons, or other material data disclosed.

30-01-2026

UPEXI, INC. filed a Form 8-K on January 30, 2026 (AccNo: 0001477932-26-000558), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing furnishing Regulation FD disclosure with attached exhibits, but the core event details, content of disclosure, and any financial statements or exhibits are NOT_DISCLOSED. No quantitative metrics, transactions, or directional impacts are specified.

30-01-2026

Spero Therapeutics, Inc. filed an 8-K on 2026-01-30 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on affected positions, individuals, reasons for change, or timing are disclosed. No quantitative metrics or financial impacts are mentioned.

30-01-2026

XAI Octagon Floating Rate & Alternative Income Trust filed a Form 8-K on January 30, 2026, disclosing under Item 8.01 Other Events. No specific details on the event, transaction, financial metrics, or impacts are provided. This appears to be a single-item voluntary filing with no quantitative data or period-over-period comparisons disclosed.

30-01-2026

ASP Isotopes Inc. filed an 8-K on January 30, 2026, reporting under Item 1.01 entry into a Material Definitive Agreement. No specific details on the agreement's terms, parties, value, or financial impact are disclosed in the available filing summary. No quantitative metrics, comparisons, or other items are mentioned.

30-01-2026

NEXGEL, INC. filed an 8-K on 2026-01-30 disclosing officer or director changes under Item 5.02, which covers departures, elections, appointments, or compensatory arrangements of certain officers. Item 9.01 references attached financial statements and exhibits. No specific details on positions affected, individuals, reasons, timing, or compensation are disclosed.

30-01-2026

30-01-2026

Blink Charging Co. filed a Form 8-K on 2026-01-30 disclosing under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, including transfer of listing. Item 9.01 covers financial statements and exhibits. No financial metrics, transaction values, or specific reasons for the delisting event were disclosed.

• ·Accession Number: 0001493152-26-004537
• ·Filing size: 205 KB
• ·Sector: not specified

30-01-2026

Madrigal Pharmaceuticals, Inc. filed an 8-K on January 30, 2026, disclosing under Item 1.01 entry into a material definitive agreement. Item 9.01 provides for financial statements and exhibits. No specific details, financial terms, impacts, or quantitative metrics are disclosed in the provided filing summary.

30-01-2026

30-01-2026

IonQ, Inc. filed a Form 8-K on January 30, 2026, reporting under Item 3.02 unregistered sales of equity securities and under Item 7.01 Regulation FD Disclosure, with exhibits listed under Item 9.01. This is a multi-item filing with no quantitative details such as transaction values, share counts, or financial impacts disclosed in the provided information. No positive or negative metrics are mentioned, resulting in purely informational disclosure.

30-01-2026

Aspira Women's Health Inc. filed an 8-K on January 30, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 lists financial statements and exhibits. No specific transaction details, dollar values, financial metrics, or performance comparisons are disclosed.

30-01-2026

SMARTFINANCIAL INC. filed a Form 8-K on January 30, 2026, under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary disclosure to comply with Regulation FD by publicly releasing material nonpublic information, with exhibits attached. No specific financial metrics, transactions, or performance details (positive, negative, or flat) are disclosed in the provided filing information.

30-01-2026

30-01-2026

urban-gro, Inc. filed an 8-K on January 30, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements, alongside Item 5.07 on submission of matters to a vote of security holders and Item 9.01 for financial statements and exhibits. No specific details on positions affected, reasons for changes, vote outcomes, or exhibit contents are disclosed. No quantitative financial metrics, performance comparisons, or directional indicators provided.

30-01-2026

CXApp Inc. filed an 8-K on January 30, 2026, specifically under Item 3.02 disclosing Unregistered Sales of Equity Securities. No details on transaction value, share count, purchasers, pricing, or exemptions are provided. This is a mandatory disclosure for equity sales exempt from Securities Act registration, with no other items or financial impacts mentioned.

30-01-2026

Ovintiv Inc. filed a Form 8-K on January 30, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This multi-item filing appears to voluntarily disclose material non-public information with attached exhibits, but specific details of the disclosure, events, or metrics are not provided. No financial impacts, transactions, or performance metrics (positive, negative, or flat) are mentioned.

30-01-2026

HEALTHY CHOICE WELLNESS CORP. filed an 8-K on January 30, 2026, under Item 5.07 disclosing the submission of matters to a vote of security holders, typically indicating results from a shareholder meeting such as director elections or auditor ratification. Item 9.01 reports financial statements and exhibits, but no specific vote outcomes, financial metrics, or quantitative details are disclosed. This appears to be a routine informational filing with no evident positive or negative directional impacts.

30-01-2026

NN Inc filed an 8-K on January 30, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, with Item 9.01 providing financial statements and exhibits. No specific details, dollar values, strategic context, or financial impacts are disclosed in the provided filing summary. This is a multi-item mandatory disclosure with no quantitative metrics or performance comparisons available.

30-01-2026

DocGo Inc. filed an 8-K on January 30, 2026, under Item 3.01, providing notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No additional details on the specific reason, financial impacts, or strategic implications are disclosed. This event signals potential liquidity and visibility challenges for shareholders.

30-01-2026

PLUG POWER INC filed an 8-K on January 30, 2026 (AccNo: 0001104659-26-008732), reporting Item 5.07 Submission of Matters to a Vote of Security Holders and Item 8.01 Other Events. Specific details on vote outcomes, proposals voted on, or the nature of other events are NOT_DISCLOSED. No financial metrics, transactions, or quantitative impacts are mentioned.

30-01-2026

Helix Acquisition Corp. III filed an 8-K on 2026-01-30 (AccNo: 0001213900-26-010350) disclosing other events under Item 8.01 and financial statements and exhibits under Item 9.01, in connection with a merger/acquisition event. No specific deal structure, parties involved, valuation, financial terms, synergies, regulatory pathways, or shareholder impacts are detailed in the filing summary. No quantitative metrics, comparisons, or scheduled events are mentioned.

30-01-2026

Mountain Lake Acquisition Corp. II filed an 8-K on January 30, 2026, reporting entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, amendments to articles of incorporation or bylaws under Item 5.03, other events under Item 8.01, with financial statements and exhibits under Item 9.01. No quantitative metrics, deal terms, parties, or performance comparisons are disclosed. Sector is not specified.

30-01-2026

Abacus Global Management, Inc. filed a Form 8-K on January 30, 2026 (AccNo: 0001628280-26-004416, Size: 216 KB), reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific events, transactions, financial metrics, or performance data disclosed in the provided information. No positive or negative metrics are mentioned.

30-01-2026

Luminar Technologies, Inc./DE filed an 8-K on January 30, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing providing voluntary disclosure of material information to ensure broad dissemination under Regulation FD, with attached exhibits. No specific financial metrics, transactions, events, or performance details are explicitly stated in the filing metadata.

30-01-2026

Cyngn Inc. filed a Form 8-K on January 30, 2026, under Item 5.03 disclosing amendments to its Articles of Incorporation or Bylaws or a change in fiscal year. Item 9.01 references financial statements and exhibits. No specific details, financial metrics, transaction values, or impacts are disclosed.

30-01-2026

Safe & Green Development Corp filed a Form 8-K on January 30, 2026, reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No positive financial metrics, growth indicators, or offsetting developments were disclosed. This event signals significant regulatory or compliance issues impacting stock market access.

30-01-2026

KBS Real Estate Investment Trust III, Inc. filed a Form 8-K on January 30, 2026, disclosing information under Item 7.01 (Regulation FD Disclosure) and providing Financial Statements and Exhibits under Item 9.01. This multi-item filing appears to be a voluntary disclosure to comply with Regulation FD, with exhibits attached, but no specific events, transactions, financial metrics, or performance data are detailed in the provided filing information. No positive or negative metrics are mentioned.